Unity Biotechnology, Inc. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2024 | 1 | -$0.46 | -$0.46 | -$0.46 |
| Q2 2024 | 1 | -$0.40 | -$0.40 | -$0.40 |
| Q3 2024 | 1 | -$0.40 | -$0.40 | -$0.40 |
Unity Biotechnology, Inc. Earnings Date And Information
Unity Biotechnology, Inc. last posted its earnings results on Monday, November 4th, 2024. The company reported $-0.38 earnings per share for the quarter, topping analysts' consensus estimates of $-0.4 by $0.02. The company had revenue of 0 for the quarter and had revenue of 0 for the year. Unity Biotechnology, Inc. has generated $-3 earnings per share over the last year ($-2.7 diluted earnings per share) and currently has a price-to-earnings ratio of -0.97. Unity Biotechnology, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Monday, November 11th, 2024 based on prior year's report dates.
Unity Biotechnology, Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 11/04/2024 | Q3 2024 | -$0.40 | -$0.38 | 0.02 | $0 | $0 |
| 08/06/2024 | Q2 2024 | -$0.31 | $0 | $0 | ||
| 05/14/2024 | Q1 2024 | -$0.57 | -$0.34 | 0.23 | $0 | |
| 04/15/2024 | Q4 2023 | -$0.28 | $1.90 M | |||
| 11/13/2023 | Q3 2023 | -$0.87 | -$1.05 | -0.18 | $0 | |
| 08/08/2023 | Q2 2023 | -$0.83 | -$0.85 | -0.02 | $0 | |
| 05/09/2023 | Q1 2023 | -$1.10 | -$0.84 | 0.26 | $0 | |
| 03/15/2023 | Q4 2022 | -$1.15 | -$0.97 | 0.18 | $-236,000 | |
| 11/08/2022 | Q3 2022 | -$0.99 | -$1.42 | -0.43 | $0 | |
| 08/12/2022 | Q2 2022 | -$2.80 | -$2.02 | 0.78 | $236,000 | |
| 05/10/2022 | Q1 2022 | -$2.60 | -$2.90 | -0.3 | $0 | |
| 03/15/2022 | Q4 2021 | -$3.10 | -$1.82 | 1.28 | $4.78 M | |
| 11/10/2021 | Q3 2021 | -$3.80 | -$2.97 | 0.83 | $0 | |
| 08/10/2021 | Q2 2021 | -$3.20 | -$3.25 | -0.05 | $0 | |
| 05/11/2021 | Q1 2021 | -$3.80 | -$2.91 | 0.89 | $0 | |
| 03/23/2021 | Q4 2020 | -$3.80 | -$3.68 | 0.12 | $0 | |
| 11/04/2020 | Q3 2020 | -$4.50 | -$5.25 | -0.75 | $0 | |
| 07/31/2020 | Q2 2020 | -$5.10 | -$3.76 | 1.34 | $0 | |
| 05/07/2020 | Q1 2020 | -$5.10 | -$5.90 | -0.8 | $0 | |
| 03/11/2020 | Q4 2019 | -$5.40 | -$3.92 | 1.48 | $105.50 M |
Unity Biotechnology, Inc. Earnings: Frequently Asked Questions
-
When is Unity Biotechnology, Inc.'s earnings date?
Unity Biotechnology, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Monday, November 11th, 2024 based off last year's report dates.
-
Did Unity Biotechnology, Inc. beat their earnings estimates last quarter?
In the previous quarter, Unity Biotechnology, Inc. (:UBX) reported $-0.38 earnings per share (EPS) to beat the analysts' consensus estimate of $-0.4 by $0.02.
-
How can I listen to Unity Biotechnology, Inc.'s earnings conference call?
The conference call for Unity Biotechnology, Inc.'s latest earnings report can be listened to online.
-
How can I read Unity Biotechnology, Inc.'s conference call transcript?
The conference call transcript for Unity Biotechnology, Inc.'s latest earnings report can be read online.
-
How much profit does Unity Biotechnology, Inc. generate each year?
Unity Biotechnology, Inc. (:UBX) has a recorded net income of $0. Unity Biotechnology, Inc. has generated $-2.7 earnings per share over the last four quarters.
-
What is Unity Biotechnology, Inc.'s price-to-earnings ratio?
Unity Biotechnology, Inc. (:UBX) has a price-to-earnings ratio of -0.97 and price/earnings-to-growth ratio is -0.03.
